BiotechTube
Home/Investors/Frazier Healthcare Partners

Frazier Healthcare Partners

Biotech Investor · 2 portfolio companies

Portfolio
2
Combined Value
$6.6B
Focus Areas
9
Top Stage
Commercial

Investment Focus

Rare Liver DiseasesCholestasisInborn Errors of Bile Acid MetabolismChronic Hepatitis Delta Virus (HDV)Genetic NeurologyCardiorenalMetabolicGastroenterologyNephrology

Portfolio Companies

CompanyValuation
Mirum Pharmaceuticals$5.3B
Ardelyx$1.3B

Frequent Co-Investors

Public market investors1 sharedNew Enterprise Associates1 sharedOrbiMed1 shared